DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

OncoGenex's Phase III Prostate Cancer Study Fully Enrolled - Analyst Blog

3 Reasons Dividend Stock Teva Pharmaceutical Industries Ltd. Could Fall

Teva Pharmaceutical Industries has been on a nice bull run for the past year. Here are three reasons why this trend might be about to reverse.

3 Reasons Actavis plc Stock Could Fall

Shares of specialty drugmaker Actavis have been ripping higher over the past two years. Here are three reasons why this trend could be coming to an end.

COPD Occurs Most Often in These 5 States

COPD affects more than 6% of the U.S. population and costs $50 billion in direct and indirect costs annually, but these five states have the highest occurrence rate in the country.

Teva Pharmaceutical Is Poised To Grow

Strong Portfolio Will Drive Growth For Mylan

3 Stocks Underperforming Today In The Health Care Sector

Teva Pharmaceuticals New Drug Aims to Reduce Asthma Attacks

Teva Pharmaceutical's reslizumab may some day offer a new treatment option for moderate and severe asthma patients.

Is It Time to Buy Hospira, Inc.'s Stock?

Hospira has had a great run over the past 12 months. Is it time to buy or sell this high-flying stock?

Is It Time to Buy Actavis plc Stock?

Shares of specialty drugmaker Actavis have been hitting all-time highs lately. With an acquisition-fueled revenue bonanza taking place, is it time to buy shares of this red-hot biopharma?
See More Articles...